SPRAVATO

Janssen’s SPRAVATO (esketamine) treatment is here. Contact us to schedule an appointment.

Toronto Ketamine Clinic is proud to offer Janssen’s Spravato (esketamine) treatment to qualified patients.

SPRAVATO® is the first prescription nasal spray, taken with an oral antidepressant, for:

Adults with treatment-resistant depression
Depressive symptoms in adults with major depressive disorder with suicidal thoughts or actions

SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic). It is not known if SPRAVATO® is safe and effective as an anesthetic medicine.

It is not known if SPRAVATO® is safe and effective for use in preventing suicide or in reducing suicidal thoughts or actions. SPRAVATO® is not for use in place of hospitalization if your healthcare provider determines that hospitalization is needed, even if improvement is experienced after the first dose of SPRAVATO®.

It is not known if SPRAVATO® is safe and effective in children.

Symptoms associated with major depressive disorder may include:

Depressed mood or feelings of sadness
Disrupted sleep
Lack of interest or inability to feel pleasure (anhedonia)
Feelings of guilt or hopelessness
Lack of energy
Difficulty concentrating
Changes in appetite or weight
Slowed thoughts or movements (psychomotor retardation)
Restlessness and/or purposeless movements (psychomotor agitation)
Suicidal thoughts or actions

Make An Appointment